¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"specific developmental disorder of motor function"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • menstrual disorder
    ¿ù°æÀå¾Ö
  • mental disorder
    Á¤½ÅÀå¾Ö
  • metabolic disorder
    ´ë»çÀå¾Ö
  • neuroleptic-induced disorder
    Ç×Á¤½Åº´¾à¹°À¯¹ßÀå¾Ö
  • neurological disorder
    ½Å°æ°èÀå¾Ö, ½Å°æ°èÁúȯ
  • neuromuscular disorder
    ½Å°æ±Ù(À°)Àå¾Ö, ½Å°æ±Ù(À°)Áúȯ
  • neurotic disorder
    ½Å°æÁõ¼ºÀå¾Ö
  • neurovascular disorder
    ½Å°æÇ÷°üÀå¾Ö
  • nutritional disorder
    ¿µ¾çÀå¾Ö
  • obsessive-compulsive disorder
    °­¹ÚÀå¾Ö, °­¹Úº´
  • obsessive-compulsive personality disorder
    °­¹ÚÀΰÝÀå¾Ö
  • oppositional defiant disorder
    ¸Â¼¶¹ÝÇ×Àå¾Ö, Àû´ëÀû¹ÝÇ×Àå¾Ö
  • organic mental disorder
    ±âÁúÁ¤½ÅÀå¾Ö, ±âÁúÁ¤½Åº´
  • organic personality disorder
    ±âÁúÀΰÝÀå¾Ö
  • overanxious disorder
    °ú´ÙºÒ¾ÈÀå¾Ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • mendelian disorder
    ¸àµ¨À¯ÀüÁúȯ
  • menstrual disorder
    ¿ù°æÀå¾Ö
  • mental disorder
    Á¤½ÅÀå¾Ö, Á¤½Åº´
  • metabolic disorder
    ´ë»çÀå¾Ö
  • micturition disorder
    ¹è´¢Àå¾Ö
  • minor depressive disorder
    °æÁõ¿ì¿ïÀå¾Ö
  • mood disorder
    ±âºÐÀå¾Ö, ±âºÐº´
  • multifactorial genetic disorder
    ´ÙÀμºÀ¯ÀüÀå¾Ö, ´ÙÀμºÀ¯ÀüÁúȯ
  • multiple personality disorder
    ´ÙÁßÀΰÝÀå¾Ö
  • myelodysplastic disorder
    °ñ¼öÇü¼ºÀÌ»óÁúȯ
  • myeloproliferative disorder
    °ñ¼öÁõ½ÄÁúȯ
  • myopathic disorder
    ±ÙÀ°º´Áõ
  • neuroleptic-induced disorder
    ½Å°æÀÌ¿ÏÁ¦À¯¹ßÀå¾Ö
  • neurological disorder
    ½Å°æ°èÀå¾Ö, ½Å°æ°èÁúȯ
  • neuromuscular disorder
    ½Å°æ±ÙÀ°Àå¾Ö, ½Å°æ±ÙÀ°Áúȯ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • motor system
    ¿îµ¿°è(ê¡ÔÑͧ).
  • motor system
    ¿îµ¿ °è(ê¡ÔÑͧ).
  • motor system disease
  • motor tic
    ¿îµ¿¼º ƽÁõ(ê¡ÔÑàõ¡­ñø).
  • motor tract
    ¿îµ¿·Î(ê¡ÔÑÖØ).
  • motor unit
    ¿îµ¿´ÜÀ§(¡­Ó¤êÈ)
  • motor wave
    ¿îµ¿ÆÄ(ê¡ÔÑ÷î).
  • motor zone
    ¿îµ¿´ë(ê¡ÔÑÓá).
  • peripheral motor neuron
    ¸»Ãʿ¼º ½Å°æ¼¼Æ÷(¡­ê¡ÔÑàõãêÌèá¬øà).
  • peripheral motor neuron
    ¸»Ãʿ¼º ½Å°æ¼¼Æ÷(¡­ê¡ÔÑàõãêÌèá¬øà).
  • prue motor hemiparesis
    ¼ø¿îµ¿ÆíÃøºÎÀü¸¶ºñ
  • somatic motor aura
    ü¼º¿îµ¿¼º ÀüÁ¶(ô÷àõê¡ÔÑàõîñð¼).
  • supplemental motor area
    º¸Á¶¿îµ¿¿µ¿ª(ÜÍð¾ê¡ÔÑçÐæ´).
  • supplemental motor area = supplementary area
    º¸Á¶¿îµ¿¿µ¿ª(ÜÍð¾ê¡ÔÑçÐæ´)
  • supplementary motor area
    º¸Á¶¿îµ¿¿µ¿ª(ÜÍð¾ê¡ÔÑçÐæ´).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
ETF electron-transferring flavoprotein; eustachian tube function
exp expansion; expectorant; experiment, experimental; expiration, expired; exponential function; exposur...
FFI family function index; free from infection; fundamental frequency indicator
fn function
FS factor of safety; Fanconi syndrome; Felty syndrome; fibromyalgia syndrome; field stimulation; Fisher...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
MCV Motor Conduction Velocity
MEP Motor Evoked Potential
MNCV Motor Nerve Conduction Velocity
MUAP Motor Unit Action Potential
MUP Motor Unit Potential
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • somatoform disorder
    ½Åü Àå¾Ö, ½ÅüÇü Àå¾Ö, ½Åüȭ Àå¾Ö
    ±âÁúÀû ¼Ò°ßÀÌ ¾ø´Â ½Åü ÁúȯÀ» ³ªÅ¸³»´Â Áõ»óÀÌ ÀÖ´Â Á¤½ÅÀû »óÅ·μ­ ÀÓ»óÀûÀ¸·Î ÀûÀÀ¼º ±â´É¿¡ ½ÉÇÑ Àå¾ÖÀÇ ¿øÀÎÀÌ µÈ´Ù. DSM-VI´Â ÀÌ·¯ÇÑ Àå¾Ö¿¡ 5°¡Áö°¡ ÀÖ´Ù´Â °ÍÀ» ¾Ë·ÁÁØ´Ù. Áï ½Åüȭ Àå¾Ö
  • somatoform pain disorder
    ½ÅüÇü ÅëÁõ Àå¾Ö
    ÁÖµÈ È£¼Ò°¡ ½ÉÇÑ ¸¸¼º ÅëÁõÀ̰í Àüȯ Àå¾ÖÀÇ Áø´Ü ±âÁØ¿¡ ¸Â´Â °ÍÀÌ Æ¯Â¡ÀÎ Á¤½Å Àå¾Ö. ƯÈ÷, ÅëÁõÀÌ ½Å°æ ÇØºÎ³ª ÀÌ¹Ì ¾Ë·ÁÁø º´»ý¸®ÇÐÀû ±âÀü¿¡ ÀÏÄ¡µÇÁö ¾Ê°í ±âÁúÀû º´¸®ÀÇ º¯È­°¡ ÀÖ´Ù ÇÏ´õ¶óµµ ÅëÁõÀÌ ¿¹»óº¸´Ù ÈξÀ ¸¹°Å³ª ¶Ç´Â Áõ»óµéÀÌ ½É¸®Àû ¿øÀÎÀ» ¸í½ÃÇÏ´Â ÁõÈĸ¦ °®°í ÀÖ´Ù.
  • speech disorder
    ¾ð¾î Àå¾Ö
    ¸»À» ¹Ù¸£°Ô ¹ßÀ½ÇÏÁö ¸øÇϰųª Á¤È®ÇÏ°Ô ÀÌÇØÇÏÁö ¸øÇÏ´Â »óÅÂ. Àΰ£Àº ¸»
  • stereotypy disorder
    »óµ¿ Àå¾Ö, »óµ¿º´
  • systemic disorder
    Àü½Å Àå¾Ö
  • vascular disorder
    Ç÷°ü Àå¾Ö, Ç÷°ü¼º Àå¾Ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
Gaucher disorder <disease> A chronic congenital disease of lipid metabolism caused by a deficiency of the beta-glucocerebrosidase enzyme. The defect is most common in Ashkenazi Jews. Clinical features are hepatosplenomegaly (enlargement of liver and spleen) and in severe early onset forms of the disease, with neurological dysfunction.
Inheritance: autosomal recessive.
(27 Sep 1997)
gene disorder Hereditary disorder caused by a mutant allele of a single gene (e.g., Duchenne muscular dystrophy, retinoblastoma, sickle cell disease).
Compare polygenic disorders.
(05 Mar 2000)
manic-depressive disorder An obsolete term for one of the mood disorders; i.e., bipolar disorder, depression; affective psychosis, affective disorder, bipolar disorder, and endogenous depression.
(05 Mar 2000)
generalised anxiety disorder Chronic, repeated episodes of anxiety reactions; a psychological disorder in which anxiety or morbid fear and dread accompanied by autonomic changes are prominent features.
See: anxiety.
(05 Mar 2000)
reactive attachment disorder Markedly disturbed and developmentally inappropriate social relatedness that begins before age 5 and is associated with grossly pathological child care. The child may persistently fail to initiate and respond to social interactions in a developmentally appropriate way (inhibited type) or there may be a pattern of diffuse attachments with nondiscriminate sociability (disinhibited type).
(12 Dec 1998)
paranoid disorder A false belief, seen most often in psychosis (for example schizophrenia).
(27 Sep 1997)
paranoid personality disorder A personality disorder characterised by the avoidance of accepting deserved blame and an unwarranted view of others as malevolent. The latter is expressed as suspiciousness, hypersensitivity, and mistrust.
(12 Dec 1998)
passive-aggressive personality disorder A personality disorder characterised by an indirect resistance to demands for adequate social and occupational performance; anger and opposition to authority and the expectations of others that is expressed covertly by obstructionism, procrastination, stubbornness, dawdling, forgetfulness, and intentional inefficiency.
(12 Dec 1998)
visceral disorder Nomenclature used in reference to psychosomatic disorder.
(05 Mar 2000)
REM behaviour disorder A disorder characterised by lack of the atonia of voluntary muscles that normally occurs in REM sleep.
(05 Mar 2000)
memory disorder Disturbances in registering an impression, in the retention of an acquired impression or in the recall of an impression.
(12 Dec 1998)
character disorder A term referring to a group of behavioural disorder's, now replaced by a more general term, personality disorder, of which character disorder's are now a subclass.
(05 Mar 2000)
mental disorder A psychological syndrome or behavioural pattern that is associated with either subjective distress or objective impairment.
See: mental illness, behaviour disorder.
(05 Mar 2000)
grandiose type of paranoid disorder A delusion in which the person believes that he or she possesses some great but unrecognised talent or insight, or has made an important discovery, with subsequent efforts toward official or public recognition.
(05 Mar 2000)
persecutory type of paranoid disorder One of the most common of the types of paranoid disorders, it involves a single theme or series of connected themes, such as being conspired against, cheated, spied on, followed, poisoned or drugged, maligned, harassed, or obstructed in the pursuit of long-term goals; small slights may be exaggerated and become the focus of a delusional system.
See: paranoia.
Compare: paranoid personality disorder.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
ÅëÇÕ°Ë»ö ¿Ï·á